This is the supplier profile page of Hangzhou Lead Biotech Co., Ltd, where buyers can explore products, connect directly with the supplier for pricing inquiries.
China
1.1
Room505-506, FloorG
Add Favorite
Report Supplier
Business Description
Our company was established in October 23,2014. Our company is mainly engaged in custom synthesis especially for complex pharmaceutical intermediates and APIs. Our R&D team is led by a senior post doctor who was graduated from Purdue University and ever worked as project director in of Li Ka-shing&＃39;s Hutchison Whampoa(Shanghai)Medicine. He ever participated in synthesis the most complex anti-tumor compound(Trabectedin , 48 steps in total) in the world when he worked as director in process and R&D department. The project is in the leading position of the world and at the stage of register and declaration currently.We have two R&D centers and the total area is 2000 square meters. We have 35 important R&D staffs and 3 cooperative plants.We are specialized in pharmaceutical intermediates and APIs and we can provide gram small pilot to commercial quantity.Representative products: Lusutrombopag(CAS:1110766-97-6), Bilastine, Retapamulin, Netupitant, Enzalutamide, etc
Business Overview
Avg Response Time
≤ 1h
Export Capabilities
Declared by supplierHangzhou Lead Biotech Co., Ltd has been exporting since 2014.
Export start year
2014
Trade Capabilities
Business Terms
Trade Ability
